Skip to content

There. You're smarter.

Articles
SmartPill
FastPoll
HealthyDose
Contact Us
About InsightCity
Search

Search for:

stat_10_3_16

Posted on September 30, 2016Full size 600 × 210

Related

Leave a Reply Cancel reply

You must be logged in to post a comment.

Post navigation

Previous Previous post: SmartPill™ for the Week of October 3, 2016

Sign up for our newsletter

First Name

Last Name

Email address:

Leave this field empty if you're human:

SmartPill™ for the Week of April 16, 2018

Antidepressant prescribing:

Source: Health and Social Care Information Center via NHS Digital

SmartPill™ for the Week of April 16, 2018
Antidepressant prescribing: Source: Health and […]
SmartPill™ for the Week of April 9, 2018
Nightmare bacteria: Source: Centers for Disease […]
SmartPill™ for the Week of April 2, 2018
Vaccinating health care workers: Source: […]
SmartPill™ for the Week of March 26, 2018
Physician salaries: Source: JAMA […]
SmartPill™ for the Week of March 19, 2018
RIP Stephen Hawking: Source: USA TODAY […]

FastPoll™ for the Week of April 9, 2018

Would a cancer warning label on coffee change your coffee consumption?

FastPoll™ for the Week of April 9, 2018
Would a cancer warning label on coffee change your coffee consumption? […]
FastPoll™ for the Week of April 2, 2018
Were you involved in an April Fool’s day prank? […]
FastPoll™ for the Week of March 26, 2018
Would you describe the last meal you ate as healthy? […]
FastPoll™ for the Week of March 19, 2018
If you were in the US House of Representatives (gross, right?), would you vote for the proposed […]
FastPoll™ for the Week of March 12, 2018
Which better describes how you feel about Allergan’s transfer of the Restasis patent to the […]

Tags

AbbVie addiction adherence advertising Aetna alcohol allergan Alzheimer’s disease Amazon Amgen antibiotic resistance antibiotics Apple apps AstraZeneca bacteria biologics biopharma biosimilars biotech breast cancer Brexit cancer Celgene China clinical research clinical trials CRISPR data depression diabetes diet direct to consumer drug approvals drug development Drug Pricing electronic health records Eli Lilly emergency department ethics exercise FDA fitness generics gene therapy genetics GSK health healthcare healthcare costs heart disease HIV hospitals immunotherapy influenza Innovation insurance lawsuits legislation M&A malaria manufacturing marketing medical device Medicare mental health Merck Mylan NHS NICE NIH Novartis obesity oncology opioids orphan drugs patients pfizer pharma pharmacy Phase I physicians prescriptions pricing public health regulation regulatory research Sanofi sleep smoking social media stem cells stroke technology Teva Trump UK vaccines wearables weight loss WHO youth zika

Sign up for updates

First Name

Last Name

Email address:

Leave this field empty if you're human:

Contact us

[email protected] | 919-230-6767

Theme: Maisha Lite designed by Anariel Design.